|
Market Cap (2-Jul) $57,232,348 (840th) |
Close (30-Jun) $0.86 |
Volume (30-Jun) 64,140 |
Shortsold (19-Jun) 737,517 (0.45%) (320th) |
|
52w High $1.12 |
52w Low $0.285 |
P/E - |
EPS -0.06 |
PIQ released this announcement to the ASX on 11 January 2023, 12:22. The announcement is not marked as price sensitive, and is 1 page(s) in length and 728.75kb in size.
You can view all announcements from PIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, PIQ was 0.000% short sold according to ASIC data. It was ranked the 654th most shorted stock on the ASX. It is now ranked as the 320th most shorted stock on the ASX with 0.451% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PIQ | |
|---|---|
| Sonic Healthcare USA signs licence for PromarkerD in the US | 10 May 2023, 11:41 |
| Trading Halt | 8 May 2023, 9:15 |
| World Endometriosis Congress - New diagnostic test showcased | 5 May 2023, 8:15 |
| Exercise of Options | 11 January 2023, 12:22 |
| Application for quotation of securities - PIQ | 11 January 2023, 12:20 |
| Letter of intent with Sonic Healthcare USA extended | 5 January 2023, 8:16 |
| CPT PLA reimbursement code approved in US for PromarkerD | 3 January 2023, 8:23 |
You must be logged in to post a reply.
Proteomics International Laboratories 